ロード中...
Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain
Purpose: The introduction of direct-acting antivirals (DAAs) has revolutionized the treatment of chronic hepatitis C viral (HCV) infection. This study aims to establish real-world treatment efficacy of Sofosbuvir-based (SOF-B) and Ombitasvir/Paritaprevir/Ritonavir-based (OPR-B) regimens. Patients an...
保存先:
| 出版年: | Hepat Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524762/ https://ncbi.nlm.nih.gov/pubmed/31191049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S190967 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|